P

PharmaResearch Co Ltd
KOSDAQ:214450

Watchlist Manager
PharmaResearch Co Ltd
KOSDAQ:214450
Watchlist
Price: 214 500 KRW -2.05%
Market Cap: 2.2T KRW
Have any thoughts about
PharmaResearch Co Ltd?
Write Note

PharmaResearch Co Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaResearch Co Ltd
Cash from Financing Activities Peer Comparison

Comparables:
068270
302440
H
145020
196170
A
298380

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
P
PharmaResearch Co Ltd
KOSDAQ:214450
Cash from Financing Activities
-â‚©17.7B
CAGR 3-Years
N/A
CAGR 5-Years
-23%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Cash from Financing Activities
-â‚©273.9B
CAGR 3-Years
N/A
CAGR 5-Years
-8%
CAGR 10-Years
-18%
SK Bioscience Co Ltd
KRX:302440
Cash from Financing Activities
-â‚©89.6B
CAGR 3-Years
-288%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Cash from Financing Activities
-â‚©232.3B
CAGR 3-Years
-204%
CAGR 5-Years
-22%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Cash from Financing Activities
â‚©33.2B
CAGR 3-Years
-42%
CAGR 5-Years
39%
CAGR 10-Years
N/A
A
ABL Bio Inc
KOSDAQ:298380
Cash from Financing Activities
â‚©1.8B
CAGR 3-Years
39%
CAGR 5-Years
-52%
CAGR 10-Years
N/A

See Also

What is PharmaResearch Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
-17.7B KRW

Based on the financial report for Jun 30, 2024, PharmaResearch Co Ltd's Cash from Financing Activities amounts to -17.7B KRW.

What is PharmaResearch Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-23%

Over the last year, the Cash from Financing Activities growth was -70%.

Back to Top